Aminoglycoside resistance rates, phenotypes, and mechanisms of Gram-negative bacteria from infected patients in upper Egypt.
about
Stenotrophomonas maltophilia PhoP, a Two-Component Response Regulator, Involved in Antimicrobial SusceptibilitiesCombined ceftazidime and amikacin resistance among Gram-negative isolates in acute-onset postoperative endophthalmitis: prevalence, antimicrobial susceptibilities, and visual acuity outcomeFrom penicillin-streptomycin to amikacin-vancomycin: antibiotic decontamination of cardiovascular homografts in SingaporeAntimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance TrialAminoglycoside Resistance in Clinical Isolates of Gram Negative Bacilli at the University Hospital of the West Indies, Jamaica: Comparison of Two Time Periods.AMINOGLYCOSIDE RESISTANCE GENES IN Pseudomonas aeruginosa ISOLATES FROM CUMANA, VENEZUELAMolecular Identification of Aminoglycoside-Modifying Enzymes and Plasmid-Mediated Quinolone Resistance Genes among Klebsiella pneumoniae Clinical Isolates Recovered from Egyptian Patients.Occurrence of aminoglycoside-modifying enzymes among isolates of Escherichia coli exhibiting high levels of aminoglycoside resistance isolated from Korean cattle farms.Occurrence of airborne vancomycin- and gentamicin-resistant bacteria in various hospital wards in Isfahan, IranCiprofloxacin-Mediated Mutagenesis Is Suppressed by Subinhibitory Concentrations of Amikacin in Pseudomonas aeruginosa.Multi-antibiotic resistant extended-spectrum beta-lactamase producing bacteria pose a challenge to the effective treatment of wound and skin infections.Commentary: Hernia, Mesh, and Topical Antibiotics, Especially Gentamycin: Seeking the Evidence for the Perfect Outcome….Amikacin: Uses, Resistance, and Prospects for Inhibition.Identification of Genes Coding Aminoglycoside Modifying Enzymes in E. coli of UTI Patients in India.
P2860
Q28551908-81C805F5-40FE-4D55-BA5D-847EBFA9BC68Q34255789-D839FA30-4FC2-4369-9D42-15504E290293Q34517001-84592389-2183-460F-9CAA-1926DFC75593Q36370098-BFC4D320-8C5A-45A9-BE71-05BE3C029934Q36418033-4CD7F209-D5D7-4410-8511-228FF9746FD3Q36720358-2267D8F5-C489-46E1-BB54-25E1149EC4B3Q38714815-703E93D3-A8AD-4DB7-9CA8-E0BC5B4D22C7Q40163452-28216EBD-D9E2-4A04-A3F1-D8F9DE3C3838Q40531160-3CF72DBF-6ED2-4492-98F6-BDB3944B8F1EQ42021837-F956A2FB-591B-42CC-8620-B4DB85B3D6E0Q47118920-B503CA4C-C1C5-4CA5-85E0-E8457E634648Q47162168-C7A12C50-6D7F-45FA-A128-01354A557CE3Q52744431-0BB5CA4F-1961-4745-B2BB-CB70CACD3146Q53777899-90AADC90-4271-44AF-BBF6-D87C67906044
P2860
Aminoglycoside resistance rates, phenotypes, and mechanisms of Gram-negative bacteria from infected patients in upper Egypt.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Aminoglycoside resistance rate ...... ected patients in upper Egypt.
@ast
Aminoglycoside resistance rate ...... ected patients in upper Egypt.
@en
type
label
Aminoglycoside resistance rate ...... ected patients in upper Egypt.
@ast
Aminoglycoside resistance rate ...... ected patients in upper Egypt.
@en
prefLabel
Aminoglycoside resistance rate ...... ected patients in upper Egypt.
@ast
Aminoglycoside resistance rate ...... ected patients in upper Egypt.
@en
P2093
P2860
P1433
P1476
Aminoglycoside resistance rate ...... ected patients in upper Egypt.
@en
P2093
Gamal F Gad
Heba A Mohamed
Hossam M Ashour
P2860
P304
P356
10.1371/JOURNAL.PONE.0017224
P407
P577
2011-02-17T00:00:00Z